KG
Kenneth R Gundle
Oregon Health & Science University, Portland VA Medical Center, Harvard Medical School, Stanford University
Research areas: Medicine · Oncology · Sarcoma Diagnosis and Treatment · Cancer Immunotherapy and Biomarkers · Bone Tumor Diagnosis and Treatments
0000-0003-0451-0561
Employment
-
Oregon Health and Science University Assistant Professor, Orthopaedic Oncology2016 - Present
-
Portland VA Medical Center Staff Orthopaedic Surgeon2016 - Present
Education
-
Harvard Medical School MD, magna cum laude2006 - 2010
-
Stanford University BA, with Honors2001 - 2005
Projects & Funding
Projects & funding information is unavailable.
Publications (66)
- Virtual or In-Person? A Census of Orthopaedic Surgery Residency Interview Formats for Match 2025 Save
- Survival of Proximal Tibial Endoprostheses Using Compressive Osseointegration: A Multi‐Institution Retrospective Study Save
- De Novo Natural Language Processing Algorithm Accurately Identifies Myxofibrosarcoma From Pathology Reports Save
- Reply to Letter to the Editor: Does “Hoarding” Impact Interview Distribution Among Orthopaedic Surgery Residency Applicants? A Modeling Study Based on a Large Database Save
- Does “Hoarding” Impact Interview Distribution Among Orthopaedic Surgery Residency Applicants? A Modeling Study Based on a Large Database Save
- Arthroplasty for Treating Proximal Femur Metastatic Lesions May Be Associated with Lower Mortality Rates Compared to Intramedullary Nailing within the VA Healthcare System Save
- Opioid Use in Surgical Management in Musculoskeletal Oncology Save
- Pediatric and Adult Patients Have Similar Functional Improvement After Endoprosthetic Reconstruction of Lower-Extremity Tumors Save
- CORR Insights®: What Are the Trends in Research Publication Misrepresentation Among Orthopaedic Residency and Fellowship Applicants From 1996 to 2019? A Systematic Review Save
- Data from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Data from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Supplemental Figure 1 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Supplemental Figure 1 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Supplemental Figure 2 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Supplemental Figure 2 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Supplemental Figure 3 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Supplemental Figure 3 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Supplemental Figure 4 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Supplemental Figure 4 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save
- Supplemental Figure 5 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma Save